<DOC>
	<DOCNO>NCT00004494</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine maximum tolerate dose vasoactive intestinal peptide patient acute respiratory distress syndrome . II . Evaluate safety pharmacodynamic activity peptide patient .</brief_summary>
	<brief_title>Phase I Study Vasoactive Intestinal Peptide Patients With Acute Respiratory Distress Syndrome Sepsis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This dose escalation study . Patients receive vasoactive intestinal peptide ( VIP ) IV either 6 12 hour . Cohorts 3 patient receive escalate dos VIP either 6 12 hour maximum tolerate dose determine . Patients follow 30 day .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Vasoactive Intestinal Peptide</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis adult respiratory distress syndrome ( ARDS ) sepsis ARDS characterize : hypoxemia refractory supplemental oxygen therapy , diffuse pulmonary infiltrates , cardiogenic cause pulmonary edema , reduce pulmonary compliance Sepsis characterize : Two follow : Fever hypothermia ; Tachycardia ; Tachypnea ; WBC great 12,000/mm3 less 4,000/mm3 immature neutrophil ; Hypotension ; Clinical suspicion infection ; Inadequate organ perfusion organ dysfunction demonstrate : Acute deterioration mental acuity ( exclude sedative nonsepsis cause ) OR Unexplained metabolic acidosis OR Oliguria great 2 hour OR Unexplained coagulopathy ( elevated PT PTT platelet count decrease less 50 % baseline within 24 hour less 100,000/mm3 ) OR Acute elevation bilirubin great 2.0 mg/dL AND elevation alkaline phosphatase , SGOT , SGPT No sepsis unstable BP Prior/Concurrent Therapy At least 30 day since prior enrollment investigational trial ; No concurrent enrollment investigational trial Patient Characteristics Hematopoietic : See Disease Characteristics ; No uncontrolled hemorrhage ( transfusion 4 unit require within past 24 hour ) ; No chemotherapy induce neutropenia ( granulocyte count le 1000/mm3 ) Hepatic : No severe liver disease portal hypertension Renal : No anuria ( urine output le 50 mL/day ) Cardiovascular : No cardiogenic shock Neurologic : No recent stroke , head trauma , increase intracranial pressure ; No serious neurologic disorder Other : Not pregnant ; No acquire immune deficiency syndrome ; No immunosuppressed transplant patient ; No severe burn ; No irreversible underlie condition rapidly fatal course ; No mark obesity ; No recent history diarrhea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1999</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>neonatal disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>respiratory distress syndrome</keyword>
	<keyword>sepsis</keyword>
</DOC>